تقرير
Antihypertensive drugs in COVID-19 infection.
| العنوان: | Antihypertensive drugs in COVID-19 infection. |
|---|---|
| المؤلفون: | Pinto-Sietsma SJ; University of Amsterdam, Amsterdam, The Netherlands., Flossdorf M; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Deutsches Zentrum für Infektionsforschung, München, Germany., Buchholz VR; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Deutsches Zentrum für Infektionsforschung, München, Germany., Offerhaus J; University of Amsterdam, Amsterdam, The Netherlands., Bleijendaal H; University of Amsterdam, Amsterdam, The Netherlands., Beudel M; University of Amsterdam, Amsterdam, The Netherlands., Volders PGA; Maastricht University, Maastricht, The Netherlands., Ter Bekke RMA; Maastricht University, Maastricht, The Netherlands., Dormans T; Zuyderland Hospital, Heerlen, The Netherlands., Zwetsloot PP; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., de Jager P; Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Massberg S; Department of Cardiology. Klinikum der Ludwig-Maximilians-Universität and Deutsches Zentrum für Herz-Kreislauf-Forschung, München, Germany., Rämer P; Department of Hospital Hygiene and infection prevention, Munich Municipal Hospital Group, München, Germany., Wendtner C; Department of Hospital Hygiene and infection prevention, Munich Municipal Hospital Group, München, Germany., Hoffmann E; Department of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich Municipal Hospital Group, Englschalkinger Str. 77, Munich, Germany., Rothe K; Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Deutsches Zentrum für Infektionsforschung, München, Germany., Feihl S; Klinikum Rechts der Isar, Technische Universität München, München, Germany., Kessler T; Department of Cardiology, Technische Universität München, Deutsches Zentrum für Herz-Kreislauf-Forschung, Munich Heart Alliance; München, Germany., Pinto YM; University of Amsterdam, Amsterdam, The Netherlands., Schunkert H; Department of Cardiology, Technische Universität München, Deutsches Zentrum für Herz-Kreislauf-Forschung, Munich Heart Alliance; München, Germany. |
| المصدر: | European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2020 Nov 01; Vol. 6 (6), pp. 415-416. |
| نوع المنشور: | Comparative Study; Letter; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Oxford : Oxford University Press, [2015]- |
| مواضيع طبية MeSH: | Antihypertensive Agents/*administration & dosage , Coronavirus Infections/*therapy , Hypertension/*drug therapy , Pneumonia, Viral/*therapy, Adrenergic beta-Antagonists/administration & dosage ; Angiotensin Receptor Antagonists/administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage ; Antihypertensive Agents/adverse effects ; COVID-19 ; Calcium Channel Blockers/administration & dosage ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Diuretics/administration & dosage ; Drug Administration Schedule ; Germany ; Hospitalization ; Humans ; Hypertension/diagnosis ; Hypertension/mortality ; Netherlands ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Protective Factors ; Risk Factors ; Treatment Outcome |
| References: | N Engl J Med. 2020 Jun 18;382(25):2441-2448. (PMID: 32356628) N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013) N Engl J Med. 2020 Jun 18;382(25):e102. (PMID: 32356626) Nature. 2005 Jul 7;436(7047):112-6. (PMID: 16001071) Lancet Respir Med. 2020 Apr;8(4):e21. (PMID: 32171062) |
| المشرفين على المادة: | 0 (Adrenergic beta-Antagonists) 0 (Angiotensin Receptor Antagonists) 0 (Angiotensin-Converting Enzyme Inhibitors) 0 (Antihypertensive Agents) 0 (Calcium Channel Blockers) 0 (Diuretics) |
| تواريخ الأحداث: | Date Created: 20200606 Date Completed: 20201125 Latest Revision: 20210110 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC7314060 |
| DOI: | 10.1093/ehjcvp/pvaa058 |
| PMID: | 32501477 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2055-6845 |
|---|---|
| DOI: | 10.1093/ehjcvp/pvaa058 |